AI Article Synopsis
Article Abstract
Study Objective: To measure the possible association between subhypnotic propofol infusion during general balanced anesthesia and the incidence of PONV.
Design: Retrospective Cohort Analysis Using Propensity Score Matching.
Setting: Postanesthesia care unit and inpatient unit.
Patients: Patients with American Society of Anesthesiologists (ASA) physical status I-IV, undergoing non-cardiac surgery lasting >2 h were included. Patients were excluded if transferred to the intensive care unit after surgery or received ketamine. Initially 70,976 patients were screened, and a cohort of 51,707 eligible adult patients undergoing non-cardiac surgery under general balanced anesthesia between 2015 and 2019 were included. Using a propensity score matching, 3185 patients who received subhypnotic propofol during general balanced anesthesia were matched with 5826 patients who did not receive subhypnotic propofol in a 1:2 ratio.
Interventions: None.
Measurements: The primary outcome was the incidence of PONV during PACU stay. The secondary outcome was the incidence of PONV within the first 24 h after surgery. Exploratory outcomes were time-to-extubation and length of hospital stay.
Main Results: A total of 9011 patients were included (3185 patients who received propofol infusion, and 5826 patients who did not receive propofol infusion) after propensity score matching. The adjusted odds ratio for PONV incidence was 1.03 (95% CI: 0.90, 1.18; p = 0.635) in PACU, and 1.05 (95% CI: 0.90, 1.23; P = 0.50) within 24 h after surgery. The length of hospital stay was 6 h shorter (ratio of means (95% CI) of 0.92, 0.89, 0.94), p < 0.001) and time-to-extubation was 2 min longer (ratio of means 1.24 (1.20, 1.28), p < 0.001) in patients receiving subhypnotic propofol infusion.
Conclusions: Our study suggests that subhypnotic propofol infusion during general balanced anesthesia is not associated with a reduction in the incidence of PONV during PACU stay and within the first 24 h after surgery. However, it is associated with decreased LOS and increased time-to-extubation, but differences in neither outcome were clinically important.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jclinane.2022.110672 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pharmacological agents for prevention of pruritus in women undergoing Caesarean delivery with neuraxial morphine: a systematic review and Bayesian network meta-analysis.
Br J Anaesth
September 2023
Washington University in Saint Louis, Anesthesiology, Barnes Jewish Hospital, Saint Louis, MO, USA.
Background: Neuraxial opioids provide effective analgesia for Caesarean delivery, however, pruritus can be a troubling side-effect. Effective agents to prevent pruritus are needed. Our objective was to perform an updated systematic review and network meta-analysis to provide clinicians with a comparison of relative efficacy of available interventions to reduce the incidence of pruritus, induced by either intrathecal or epidural single-shot morphine, in women undergoing Caesarean delivery.
View Article and Find Full Text PDFComment on: "Effect of intraoperative subhypnotic infusion of propofol on postoperative nausea and vomiting: A retrospective analysis".
J Clin Anesth
September 2022
Department of Anesthesiology, Qingdao women's and Children's Hospital Affiliated to Qingdao University, Qingdao 266000, People's Republic of China. Electronic address:
Comparison of equipotent doses of Ramosetron, Ondansetron, and sub-hypnotic dose of Propofol for prevention of postoperative nausea and vomiting in laparoscopic cholecystectomy.
J Anaesthesiol Clin Pharmacol
November 2021
Department of Anaesthesiology and Critical Care, Shrimati Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, India.
Background And Aims: For prevention of Postoperative nausea vomiting (PONV) in laparoscopic surgery, ramosetron is a selective 5-HT3 receptor antagonist with higher receptor affinity and slow dissociation than ondansetron. We compared these 2 drugs with propofol which has also shown antiemetic properties. The aim was to study ondansetron, ramosetron, and propofol with respect to incidence of PONV, its severity and the need for rescue antiemetic along with the side effects.
View Article and Find Full Text PDFEffect of intraoperative subhypnotic infusion of propofol on postoperative nausea and vomiting: A retrospective analysis.
J Clin Anesth
June 2022
Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, United States; Department of General Anesthesia, Cleveland Clinic, Cleveland, OH, United States. Electronic address:
Study Objective: To measure the possible association between subhypnotic propofol infusion during general balanced anesthesia and the incidence of PONV.
Design: Retrospective Cohort Analysis Using Propensity Score Matching.
Setting: Postanesthesia care unit and inpatient unit.
Effect of continuous infusion of a subhypnotic dose of propofol on nausea and vomiting after carboprost administration at cesarean delivery: A randomized, double-blind, placebo-controlled trial.
Int J Gynaecol Obstet
May 2022
Department of Anesthesiology and Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
Objective: To investigate whether continuous infusion of propofol at a subhypnotic dose prevents nausea and vomiting following carboprost administration at cesarean delivery.
Methods: A prospective, randomized, double-blind, placebo-controlled trial conducted at West China Second University Hospital, from June 28, 2017 to January 30, 2018. Pregnant women were randomly allocated to propofol or saline infusion immediately before receiving carboprost at cesarean delivery under combined spinal-epidural (CSE) anesthesia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!